Download PDF Register Interest

Global pipeline

Pain / CNS

S-297995 (Naldemedine)
Opioid-induced constipation
+
Phase 1
USA: Phase I

+
Phase 2

+
Phase 3
Global: Phase III
Japan: Phase III

+
Regulatory approval
NDA submission (in preparation)
S-117957
Insomnia
+
Phase 1
USA: Phase I

+
Phase 2

+
Phase 3

+
Regulatory approval
S-120083
Inflammatory pain
+
Phase 1
Japan: Phase I

+
Phase 2

+
Phase 3

+
Regulatory approval
S-010887
Neuropathic pain
+
Phase 1
Japan: Phase I

+
Phase 2

+
Phase 3

+
Regulatory approval